Budding of enveloped viruses: Interferon-induced ISG15 - Antivirus mechanisms targeting the release process

Advances in Virology

Volumn 2012, Issue , 2012, Pages

  Seo, Eun Joo ^a   Leis, Jonathan ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84868123469     PISSN: 16878639     EISSN: 16878647     Source Type: Journal    
DOI: 10.1155/2012/532723     Document Type: Article

References (116)

1. Demirov D. G., Freed E. O., Retrovirus budding. Virus Research 2004 106 2 87 102 2-s2.0-9744221135 10.1016/j.virusres.2004.08.007
2. Martin-Serrano J., Zang T., Bieniasz P. D., HIV-1 and Ebola virus encode small peptide motifs that recruit Tsg101 to sites of particle assembly to facilitate egress. Nature Medicine 2001 7 12 1313 1319 2-s2.0-0035658023 10.1038/nm1201-1313
3. Martin-Serrano J., The role of ubiquitin in retroviral egress. Traffic 2007 8 10 1297 1303 2-s2.0-34548580258 10.1111/j.1600-0854.2007.00609.x
4. Patnaik A., Chau V., Wills J. W., Ubiquitin is part of the retrovirus budding machinery. Proceedings of the National Academy of Sciences of the United States of America 2000 97 24 13069 13074 2-s2.0-0034700146 10.1073/pnas.97.24. 13069
5. Vana M. L., Tang Y., Chen A., Medina G., Carter C., Leis J., Role of Nedd4 and ubiquitination of rous sarcoma virus Gag in budding of virus-like particles from cells. Journal of Virology 2004 78 24 13943 13953 2-s2.0-10044287455 10.1128/JVI.78.24.13943-13953.2004
6. Zhadina M., Bieniasz P. D., Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. Plos Pathogens 2010 6 10 2-s2.0-78449244125 10.1371/journal.ppat.1001153 e1001153
7. Medina G., Zhang Y., Tang Y., Gottwein E., Vana M. L., Bouamr F., Leis J., Carter C. A., The functionally exchangeable L domains in RSV and HIV-1 Gag direct particle release through pathways linked by Tsg101. Traffic 2005 6 10 880 894 2-s2.0-24944515501 10.1111/j.1600-0854.2005.00323.x
8. Ono A., Freed E. O., Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proceedings of the National Academy of Sciences of the United States of America 2001 98 24 13925 13930 2-s2.0-0035923525 10.1073/pnas.241320298
9. Kikonyogo A., Bouamr F., Vana M. L., Xiang Y., Aiyar A., Carter C., Leis J., Proteins related to the Nedd4 family of ubiquitin protein ligases interact with the L domain of Rous sarcoma virus and are required for gag budding from cells. Proceedings of the National Academy of Sciences of the United States of America 2001 98 20 11199 11204 2-s2.0-0035949489 10.1073/pnas.201268998
10. VerPlank L., Agresta B., Grassa T., Kikonyogo A., Leis J., Carter C., Tsg101, the prototype of a class of dominant-negative ubiquitin regulators, binds human immunodeficiency virus type 1 Pr55Gag: the L domain is a determining of binding. Proceedings National Academy Science USA 2001 98 7724 7729 2-s2.0-41849116366
11. Dilley K. A., Gregory D., Johnson M. C., Vogt V. M., An LYPSL late domain in the Gag protein contributes to the efficient release and replication of Rous sarcoma virus. Journal of Virology 2010 84 13 6276 6287 2-s2.0-77953312134 10.1128/JVI.00238-10
12. Strack B., Calistri A., Craig S., Popova E., Göttlinger H. G., AIP1/ALIX is a binding partner for HIV-1 p6 and EIAV p9 functioning in virus budding. Cell 2003 114 6 689 699 2-s2.0-0141844660 10.1016/S0092-8674(03)00653-6
13. Gottlinger H. G., Dorfman T., Sodroski J. G., Haseltine W. A., Effect of mutations affecting the p6 gag protein on human immunodeficiency virus particle release. Proceedings of the National Academy of Sciences of the United States of America 1991 88 8 3195 3199 2-s2.0-0026317877
14. Wills J. W., Cameron C. E., Wilson C. B., Xiang Y., Bennett R. P., Leis J., An assembly domain of the Rous sarcoma virus Gag protein required late in budding. Journal of Virology 1994 68 10 6605 6618 2-s2.0-0028070639
15. gaglate assembly domain. Journal of Virology 1996 70 8 5695 5700 2-s2.0-0029978648
16. Puffer B. A., Parent L. J., Wills J. W., Montelaro R. C., Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein. Journal of Virology 1997 71 9 6541 6546 2-s2.0-0030858622
17. Medina G., Pincetic A., Ehrlich L. S., Zhang Y., Tang Y., Leis J., Carter C. A., Tsg101 can replace Nedd4 function in ASV Gag release but not membrane targeting. Virology 2008 377 1 30 38 2-s2.0-44849109935 10.1016/j.virol.2008.04. 024
18. Ott D. E., Coren L. V., Sowder R. C., Adams J., Schubert U., Retroviruses have differing requirements for proteasome function in the budding process. Journal of Virology 2003 77 6 3384 3393 2-s2.0-0037334391 10.1128/JVI.77.6.3384- 3393.2003
19. Chung H.-Y., Moirta E., Schwedler U., Nedd4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. Journal Virology 2008 82 10 4884 4897 10.1128/JVI.02667-07
20. Usami Y., Popov S., Popova E., Göttlinger H. G., Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. Journal of Virology 2008 82 10 4898 4907 2-s2.0-43249110449 10.1128/JVI.02675-07
21. Weiss E., Popova E., Yamanaka H., Kim H., Huibregtse J., Gottlinger H., Rescue of HIV-1 release by targeting widely divergent Nedd4-type ubiquitin ligases and isolated catalytic hect domains to Gag. Plos Pathogens 2010 6 13 e1001107
22. Bouamr F., Melillo J. A., Wang M. Q., Nagashima K., De Los Santos M., Rein A., Goff S. P., PPPYEPTAP motif is the late domain of human T-Cell leukemia virus Type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101. Journal of Virology 2003 77 22 11882 11895 2-s2.0-0242331750 10.1128/JVI.77.22.11882-11895.2003
23. Gottwein E., Bodem J., Müller B., Schmechel A., Zentgraf H., Kräusslich H. G., The Mason-Pfizer monkey virus PPPY and PSAP motifs both contribute to virus release. Journal of Virology 2003 77 17 9474 9485 2-s2.0-0042389562 10.1128/JVI.77.17.9474-9485.2003
24. Carlton J. G., Martin-Serrano J., Parallels between cytokinesis and retroviral budding: a role for the budding: a role for the ESCRT. Science 2007 316 5833 1908 1912 2-s2.0-34347385894 10.1126/science.1143422
25. von Schwedler U. K., Stuchell M., Muller B., The protein network of HIV budding. Cell 2003 114 701 713
26. Babst M., A protein's final ESCRT. Traffic 2005 6 1 2 9 2-s2.0-12444347534 10.1111/j.1600-0854.2004.00246.x
27. Garrus J. E., von Schwedler U. K., Pornillos O. W., Morham S. G., Zavitz K. H., Wang H. E., Wettstein D. A., Stray K. M., Côté M., Rich R. L., Myszka D. G., Sundquist W. I., Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001 107 1 55 65 2-s2.0-17944363138 10.1016/S0092-8674(01)00506-2
28. Pincetic A., Medina G., Carter C., Leis J., Avian sarcoma virus and human immunodeficiency virus, type 1 use different subsets of ESCRT proteins to facilitate the budding process. Journal of Biological Chemistry 2008 283 44 29822 29830 2-s2.0-57649158619 10.1074/jbc.M804157200
29. Pincetic A., Leis J., The mechanism of budding of retroviruses from cell membranes. Advances in Virology 2009 2009 9 623969 10.1155/2009/623969
30. Lata S., Schoehn G., Solomons J., Pires R., Göttlinger H. G., Weissenhorn W., Structure and function of ESCRT-III. Biochemical Society Transactions 2009 37 1 156 160 2-s2.0-59749090021 10.1042/BST0370156
31. Morita E., Sandrin V., McCullough J., Katsuyama A., Baci Hamilton I., Sundquist W. I., ESCRT-III protein requirements for HIV-1 budding. Cell Host and Microbe 2011 9 3 235 242 2-s2.0-79952640255 10.1016/j.chom.2011.02.004
32. Scott A., Chung H. Y., Gonciarz-Swiatek M., Hill G. C., Whitby F. G., Gaspar J., Holton J. M., Viswanathan R., Ghaffarian S., Hill C. P., Sundquist W. I., Structural and mechanistic studies of VPS4 proteins. The EMBO Journal 2005 24 20 3658 3669 2-s2.0-27144444327 10.1038/sj.emboj.7600818
33. Tsang H. T. H., Connell J. W., Brown S. E., Thompson A., Reid E., Sanderson C. M., A systematic analysis of human CHMP protein interactions: additional MIT domain-containing proteins bind to multiple components of the human ESCRT III complex. Genomics 2006 88 3 333 346 2-s2.0-33747795207 10.1016/j.ygeno.2006.04.003
34. Kieffer C., Skalicky J. J., Morita E., De Domenico I., Ward D. M., Kaplan J., Sundquist W. I., Two distinct modes of ESCRT-III recognition are required for VPS4 functions in lysosomal protein targeting and HIV-1 budding. Developmental Cell 2008 15 1 62 73 2-s2.0-46049099346 10.1016/j.devcel.2008.05. 014
35. Stuchell-Brereton M. D., Skalicky J. J., Kieffer C., Karren M. A., Ghaffarian S., Sundquist W. I., ESCRT-III recognition by VPS4 ATPases. Nature 2007 449 7163 740 744 2-s2.0-35148900389 10.1038/nature06172
36. 5 in multivesicular body formation and HIV-1 budding in mammalian cells. Journal of Biological Chemistry 2005 280 11 10548 10555 2-s2.0-15444369744 10.1074/jbc.M413734200
37. Shim S., Merrill S. A., Hanson P. I., Novel interactions of ESCRT-III with LIP5 and VPS4 and their implications for ESCRT-III disassembly. Molecular Biology of the Cell 2008 19 6 2661 2672 2-s2.0-46049118283 10.1091/mbc.E07-12- 1263
38. Azmi I. F., Davies B. A., Xiao J., Babst M., Xu Z., Katzmann D. J., ESCRT-III family members stimulate Vps4 ATPase activity directly or via Vta1. Developmental Cell 2008 14 1 50 61 2-s2.0-37749048772 10.1016/j.devcel.2007.10. 021
39. Perez M., Craven R. C., de la Torre J. C., The small RING finger protein Z drives arenavirus budding: implications for antiviral strategies. Proceedings of the National Academy of Sciences of the United States of America 2003 100 22 12978 12983 2-s2.0-0242331609 10.1073/pnas.2133782100
40. Urata S., Noda T., Kawaoka Y., Yokosawa H., Yasuda J., Cellular factors required for Lassa virus budding. Journal of Virology 2006 80 8 4191 4195 2-s2.0-33645797370 10.1128/JVI.80.8.4191-4195.2006
41. Urata S., Noda T., Kawaoka Y., Morikawa S., Yokosawa H., Yasuda J., Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. Journal of Virology 2007 81 9 4895 4899 2-s2.0-34247633960 10.1128/JVI.02829-06
42. Lambert C., Döring T., Prange R., Hepatitis B virus maturation is sensitive to functional inhibition of ESCRT-III, Vps4, and γ 2-adaptin. Journal of Virology 2007 81 17 9050 9060 2-s2.0-34548157926 10.1128/JVI.00479-07
43. Crump C. M., Yates C., Minson T., Herpes simplex virus type 1 cytoplasmic envelopment requires functional Vps4. Journal of Virology 2007 81 14 7380 7387 2-s2.0-34447265020 10.1128/JVI.00222-07
44. Schmitt A. P., Leser G. P., Morita E., Sundquist W. I., Lamb R. A., Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. Journal of Virology 2005 79 5 2988 2997 2-s2.0-13944252828 10.1128/JVI.79.5.2988-2997.2005
45. Li M., Schmitt P. T., Li Z., McCrory T. S., He B., Schmitt A. P., Mumps virus matrix, fusion, and nucleocapsid proteins cooperate for efficient production of virus-like particles. Journal of Virology 2009 83 14 7261 7272 2-s2.0-67650407490 10.1128/JVI.00421-09
46. Irie T., Harty R. N., L-domain flanking sequences are important for host interactions and efficient budding of vesicular stomatitis virus recombinants. Journal of Virology 2005 79 20 12617 12622 2-s2.0-26444514404 10.1128/JVI.79.20.12617-12622.2005
47. Wirblich C., Tan G. S., Papaneri A., Godlewski P. J., Orenstein J. M., Harty R. N., Schnell M. J., PPEY motif within the Rabies Virus (RV) matrix protein is essential for efficient virion release and RV pathogenicity. Journal of Virology 2008 82 19 9730 9738 2-s2.0-52649094943 10.1128/JVI.00889-08
48. Harty R. N., Brown M. E., Wang G., Huibregtse J., Hayes F. P., A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proceedings of the National Academy of Sciences of the United States of America 2000 97 25 13871 13876 2-s2.0-0034610295 10.1073/pnas.250277297
49. Okumura A., Pitha P. M., Harty R. N., ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proceedings of the National Academy of Sciences of the United States of America 2008 105 10 3974 3979 2-s2.0-41649084195 10.1073/pnas.0710629105
50. Silvestri L. S., Ruthel G., Kallstrom G., Warfield K. L., Swenson D. L., Nelle T., Iversen P. L., Bavari S., Aman M. J., Involvement of vacuolar protein sorting pathway in Ebola virus release independent of TSG101 interaction. Journal of Infectious Diseases 2007 196 supplement 2 S264 S270 2-s2.0-38449117567 10.1086/520610
51. Timmins J., Schoehn G., Ricard-Blum S., Scianimanico S., Vernet T., Ruigrok R. W. H., Weissenhorn W., Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. Journal of Molecular Biology 2003 326 2 493 502 2-s2.0-0037436346 10.1016/S0022-2836(02)01406-7
52. Ariumi Y., Kuroki M., Maki M., Ikeda M., Dansako H., Wakita T., Kato N., The ESCRT system is required for hepatitis C virus production. Plos ONE 2011 6 1 1 10 2-s2.0-79251580950 10.1371/journal.pone.0014517
53. Corless L., Crump C. M., Griffin S. D. C., Harris M., Vps4 and the ESCRT-III complex are required for the release of infectious hepatitis C virus particles. Journal of General Virology 2010 91 2 362 372 2-s2.0-76249128583 10.1099/vir.0.017285-0
54. Pawliczek T., Crump C. M., Herpes simplex virus type 1 production requires a functional ESCRT-III complex but is independent of TSG101 and ALIX expression. Journal of Virology 2009 83 21 11254 11264 2-s2.0-70350322311 10.1128/JVI.00574-09
55. Taylor G. M., Hanson P. I., Kielian M., Ubiquitin depletion and dominant-negative VPS4 inhibit rhabdovirus budding without affecting alphavirus budding. Journal of Virology 2007 81 24 13631 13639 2-s2.0-37049034076 10.1128/JVI.01688-07
56. Schmitt A. P., Leser G. P., Waning D. L., Lamb R. A., Requirements for budding of paramyxovirus simian virus 5 virus-like particles. Journal of Virology 2002 76 8 3952 3964 2-s2.0-0036194519 10.1128/JVI.76.8.3952-3964.2002
57. Salditt A., Koethe S., Pohl C., Measles virus M protein-driven particle production does not involve the endosomal sorting complex required for transport (ESCRT) system. Journal General Virology 2010 91 1464 1472
58. Utley T. J., Ducharme N. A., Varthakavi V., Shepherd B. E., Santangelo P. J., Lindquist M. E., Goldenring J. R., Crowe J. E., Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proceedings of the National Academy of Sciences of the United States of America 2008 105 29 10209 10214 2-s2.0-48249116345 10.1073/pnas.0712144105
59. Fraile-Ramos A., Pelchen-Matthews A., Risco C., Rejas M. T., Emery V. C., Hassan-Walker A. F., Esteban M., Marsh M., The ESCRT machinery is not required for human cytomegalovirus envelopment. Cellular Microbiology 2007 9 12 2955 2967 2-s2.0-35948940082 10.1111/j.1462-5822.2007.01024.x
60. Tandon R., AuCoin D. P., Mocarski E. S., Human cytomegalovirus exploits ESCRT machinery in the process of virion maturation. Journal of Virology 2009 83 20 10797 10807 2-s2.0-70349748558 10.1128/JVI.01093-09
61. Irie T., Licata J. M., McGettigan J. P., Schnell M. J., Harty R. N., Budding of PPxY-containing rhabdoviruses is not dependent on host proteins TSG101 and VPS4A. Journal of Virology 2004 78 10 5532 2-s2.0-2342637150 10.1128/JVI.78.10.5532.2004
62. Chen B. J., Lamb R. A., Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 2007 372 2 221 232 2-s2.0-39549095341 10.1016/j.virol.2007.11.008
63. Lai J. C. C., Chan W. W. L., Kien F., Nicholls J. M., Peiris J. S. M., Garcia J. M., Formation of virus-like particles from human cell lines exclusively expressing influenza neuraminidase. Journal of General Virology 2010 91 9 2322 2330 2-s2.0-77956270840 10.1099/vir.0.019935-0
64. Rossman J. S., Jing X., Leser G. P., Lamb R. A., Influenza virus M2 protein mediates ESCRT-independent membrane scission. Cell 2010 142 6 902 913 2-s2.0-77956637693 10.1016/j.cell.2010.08.029
65. Rossman J. S., Jing X., Leser G. P., Balannik V., Pinto L. H., Lamb R. A., Influenza virus M2 ion channel protein is necessary for filamentous virion formation. Journal of Virology 2010 84 10 5078 5088 2-s2.0-77951437276 10.1128/JVI.00119-10
66. Yondola M. A., Fernandes F., Belicha-Villanueva A., Uccelini M., Gao Q., Carter C., Palese P., Budding capability of the influenza virus neuraminidase can be modulated by tetherin. Journal of Virology 2011 85 6 2480 2491 2-s2.0-79952135872 10.1128/JVI.02188-10
67. Goodbourn S., Didcock L., Randall R. E., Interferons: cell signalling, immune modulation, antiviral responses and virus countermeasures. Journal of General Virology 2000 81 10 2341 2364 2-s2.0-0033795196
68. Guidotti L. G., Chisari F. V., Noncytolytic control of viral infections by the innate and adaptive immune response. Annual Review of Immunology 2001 19 65 91 2-s2.0-0035062597 10.1146/annurev.immunol.19.1.65
69. Neil S., Bieniasz P., Human immunodeficiency virus, restriction factors, and interferon. Journal of Interferon and Cytokine Research 2009 29 9 569 580 2-s2.0-70349235715 10.1089/jir.2009.0077
70. Wolf D., Goff S. P., Host restriction factors blocking retroviral replication. Annual Review of Genetics 2008 42 143 163 2-s2.0-58549083988 10.1146/annurev.genet.42.110807.091704
71. Donahue J. P., Vetter M. L., Mukhtar N. A., D'Aquila R. T., The HIV-1 Vif PPLP motif is necessary for human APOBEC3G binding and degradation. Virology 2008 377 1 49 53 2-s2.0-46549089412 10.1016/j.virol.2008.04.017
72. Sebastian S., Luban J., TRIM5 α selectively binds a restriction-sensitive retroviral capsid. Retrovirology 2005 2, article 40 2-s2.0-27344435418 10.1186/1742-4690-2-40
73. Stremlau M., Perron M., Lee M., Li Y., Song B., Javanbakht H., Diaz-Griffero F., Anderson D. J., Sundquist W. I., Sodroski J., Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5 α restriction factor. Proceedings of the National Academy of Sciences of the United States of America 2006 103 14 5514 5519 2-s2.0-33645794537 10.1073/pnas.0509996103
74. Sakuma T., Noda T., Urata S., Kawaoka Y., Yasuda J., Inhibition of Lassa and Marburg virus production by tetherin. Journal Virology 2009 83 5 2382 2385 10.1128/JVI.01607-08
75. Neil S. J. D., Zang T., Bieniasz P. D., Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008 451 7177 425 430 2-s2.0-38549095979 10.1038/nature06553
76. Van Damme N., Goff D., Katsura C., The interferon-induced protein BST-2 restricts HIV-1 release and is down regulated from the cell surface by the viral Vpu protein. Cell Host & Microbe 2008 3 4 245 252
77. Kuhl B. D., Sloan R. D., Donahue D. A., Bar-Magen T., Liang C., Wainberg M. A., Tetherin restricts direct cell-to-cell infection of HIV-1. Retrovirology 2010 7, article 115 2-s2.0-78650448783 10.1186/1742-4690-7-115
78. Dao C. T., Zhang D. E., ISG15: a ubiquitin-like enigma. Frontiers in Bioscience 2005 10 2 2701 2722 2-s2.0-21344473677
79. Haller O., Kochs G., Weber F., The interferon response circuit: induction and suppression by pathogenic viruses. Virology 2006 344 1 119 130 2-s2.0-29144501207 10.1016/j.virol.2005.09.024
80. Bednarik D. P., Mosca J. D., Raj N. B. K., Pitha P. M., Inhibition of human immunodeficiency virus (HIV) replication by HIV-trans-activated α 2-interferon. Proceedings of the National Academy of Sciences of the United States of America 1989 86 13 4958 4962 2-s2.0-0346299869
81. Harty R. N., Pitha P. M., Okumura A., Antiviral activity of innate immune protein ISG15. Journal of Innate Immunity 2009 1 5 397 404 2-s2.0-77951481221 10.1159/000226245
82. Jeon Y. J., Yoo H. M., Chung C. H., ISG15 and immune diseases. Biochimica et Biophysica Acta 2010 1802 5 485 496 2-s2.0-77950368491 10.1016/j.bbadis. 2010.02.006
83. Kuang Z., Seo E. J., Leis J., Mechanism of inhibition of retrovirus release from cells by interferon-induced gene ISG15. Journal of Virology 2011 85 14 7153 7161 2-s2.0-79960406323 10.1128/JVI.02610-10
84. Pincetic A., Kuang Z., Seo E. J., Leis J., The interferon-induced gene ISG15 blocks retrovirus release from cells late in the budding process. Journal of Virology 2010 84 9 4725 4736 2-s2.0-77950839509 10.1128/JVI.02478-09
85. Poli G., Orenstein J. M., Kinter A., Folks T. M., Fauci A. S., Interferon- α but not AZT suppresses HIV expression in chronically infected cell lines. Science 1989 244 4904 575 577 2-s2.0-0024364803
86. Shirazi Y., Pitha P. M., Alpha interferon inhibits early stages of the human immunodeficiency virus type 1 replication cycle. Journal of Virology 1992 66 3 1321 1328 2-s2.0-0026558049
87. Skaug B., Chen Z. J., Emerging role of ISG15 in antiviral immunity. Cell 2010 143 2 187 190 2-s2.0-77957785465 10.1016/j.cell.2010.09.033
88. Zou W., Papov V., Malakhova O., Il Kim K., Dao C., Li J., Zhang D. E., ISG15 modification of ubiquitin E2 Ubc13 disrupts its ability to form thioester bond with ubiquitin. Biochemical and Biophysical Research Communications 2005 336 1 61 68 2-s2.0-24344449085 10.1016/j.bbrc.2005.08.038
89. Chang Y. G., Yan X. Z., Xie Y. Y., Gao X. C., Song A. X., Zhang D. E., Hu H. Y., Different roles for two ubiquitin-like domains of ISG15 in protein modification. Journal of Biological Chemistry 2008 283 19 13370 13377 2-s2.0-45149122553 10.1074/jbc.M800162200
90. Narasimhan J., Wang M., Fu Z., Klein J. M., Haas A. L., Kim J. J. P., Crystal structure of the interferon-induced ubiquitin-like protein ISG15. Journal of Biological Chemistry 2005 280 29 27356 27365 2-s2.0-22844450969 10.1074/jbc.M502814200
91. Loeb K. R., Haas A. L., The interferon-inducible 15-kDa ubiquitin homolog conjugates to intracellular proteins. Journal of Biological Chemistry 1992 267 11 7806 7813 2-s2.0-0026722530
92. Zhao C., Denison C., Huibregtse J. M., Gygi S., Krug R. M., Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proceedings of the National Academy of Sciences of the United States of America 2005 102 29 10200 10205 2-s2.0-22544487172 10.1073/pnas.0504754102
93. Zhao C., Hsiang T.-Y., Kuo R. L., Krug R. M., ISG15 conjugation system targets the viral NS1 protein in influenza A virus-infected cells. Proceedings of the National Academy of Sciences of the United States of America 2010 107 5 2253 2258 2-s2.0-76649140147 10.1073/pnas.0909144107
94. Giannakopoulos N. V., Arutyunova E., Lai C., Lenschow D. J., Haas A. L., Virgin H. W., ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of sindbis virus. Journal of Virology 2009 83 4 1602 1610 2-s2.0-59649112605 10.1128/JVI.01590-08
95. Yuan W., Krug R. M., Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. The EMBO Journal 2001 20 3 362 371 2-s2.0-0035253852 10.1093/emboj/20.3.362
96. Kim K. L., Giannakopoulos N. V., Virgin H. W., Zhang D. E., Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation. Molecular and Cellular Biology 2004 24 21 9592 9600 2-s2.0-6344282196 10.1128/MCB.24.21.9592-9600.2004
97. Zhadina M., Bieniasz P. D., Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. Plos Pathog 2010 6 10 e1001153 10.1371/journal.ppat.1001153
98. Dastur A., Beaudenon S., Kelley M., Krug R. M., Huibregtse J. M., Herc5, an interferon-induced HECT E3 enzyme, is required for conjugation of ISG15 in human cells. Journal of Biological Chemistry 2006 281 7 4334 4338 2-s2.0-33645230779 10.1074/jbc.M512830200
99. Wong J. J. Y., Pung Y. F., Sze N. S. K., Chin K. C., HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proceedings of the National Academy of Sciences of the United States of America 2006 103 28 10735 10740 2-s2.0-33746089547 10.1073/pnas.0600397103
100. Giannakopoulos N. V., Luo J. K., Papov V., Zou W., Lenschow D. J., Jacobs B. S., Borden E. C., Li J., Virgin H. W., Zhang D. E., Proteomic identification of proteins conjugated to ISG15 in mouse and human cells. Biochemical and Biophysical Research Communications 2005 336 2 496 506 2-s2.0-24644474832 10.1016/j.bbrc.2005.08.132
101. Chen L., Li S., McGilvray I., The ISG15/USP18 ubiquitin-like pathway (ISGylation system) in Hepatitis C Virus infection and resistance to interferon therapy. International Journal of Biochemistry and Cell Biology 2011 43 10 1427 1431 2-s2.0-79959871296 10.1016/j.biocel.2011.06.006
102. Pitha-Rowe I. F., Pitha P. M., Viral defense, carcinogenesis and ISG15: novel roles for an old ISG. Cytokine and Growth Factor Reviews 2007 18 5-6 409 417 2-s2.0-34548129591 10.1016/j.cytogfr.2007.06.017
103. Okumura A., Lu G., Pitha-Rowe I., Pitha P. M., Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proceedings of the National Academy of Sciences of the United States of America 2006 103 5 1440 1445 2-s2.0-31944435603 10.1073/pnas.0510518103
104. Pitha P. M., Fernie B., Maldarelli F., Hattman T., Wivel N. A., Effect of interferon on mouse leukemia virus (MuLV). V. abnormal proteins on virions of Rauscher MuLV produced in the presence of interferon. Journal General Virology 1980 46 1 97 110
105. Lenschow D. J., Lai C., Frias-Staheli N., Giannakopoulos N. V., Lutz A., Wolff T., Osiak A., Levine B., Schmidt R. E., García-Sastre A., Leib D. A., Pekosz A., Knobeloch K. P., Horak I., Virgin H. W., IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proceedings of the National Academy of Sciences of the United States of America 2007 104 4 1371 1376 2-s2.0-33846603312 10.1073/pnas. 0607038104
106. Werneke S. W., Schilte C., Rohatgi A., ISG15 is critical in the control of Chikungunya virus infection independent of UbE1L mediated conjugation. Plos Pathogens 2011 7 10 e1002322 10.1371/journal.ppat.1001107
107. Lenschow D. J., Giannakopoulos N. V., Gunn L. J., Johnston C., O'Guin A. K., Schmidt R. E., Levine B., Virgin H. W., Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. Journal of Virology 2005 79 22 13974 13983 2-s2.0-27644498395 10.1128/JVI.79.22.13974-13983.2005
108. Malakhova O. A., Zhang D. E., ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. Journal of Biological Chemistry 2008 283 14 8783 8787 2-s2.0-44049102828 10.1074/jbc.C800030200
109. Mangeat B., Gers-Huber G., Lehmann M., Zufferey M., Luban J., Piguet V., HIV-1 Vpu neutralizes the antiviral factor tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathogens 2009 5 9 2-s2.0-70349663496 10.1371/journal.ppat.1000574 e1000574
110. Pardieu C., Vigan R., Wilson S. J., Calvi A., Zang T., Bieniasz P., Kellam P., Towers G. J., Neil S. J., The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. Plos pathogens 2010 6 4 16 e1000843 2-s2.0-77952830919 10.1371/journal.ppat.1000843
111. Versteeg G. A., Hale B. G., van Boheemen S., Wolff T., Lenschow D. J., García-Sastre A., Species-specific antagonism of host ISGylation by the influenza B virus NS1 protein. Journal of Virology 2010 84 10 5423 5430 2-s2.0-77951480439 10.1128/JVI.02395-09
112. Yuan W., Aramini J. M., Montelione G. T., Krug R. M., Structural basis for ubiquitin-like ISG 15 protein binding to the NS1 protein of influenza B virus: a protein-protein interaction function that is not shared by the corresponding N-terminal domain of the NS1 protein of influenza A virus. Virology 2002 304 2 291 301 2-s2.0-12244278334 10.1006/viro.2002.1663
113. Li L., Wang D., Jiang Y., Crystal structure of human ISG15 protein in complex with Influenza B Virus NS1B. Journal Biological Chemistry 2011 286 35 30258 30262
114. Arguello M. D., Hiscott J., Ub surprised: viral ovarian tumor domain proteases remove ubiquitin and ISG15 conjugates. Cell Host and Microbe 2007 2 6 367 369 2-s2.0-36749050286 10.1016/j.chom.2007.11.005
115. Sun Z., Li Y., Ransburgh R., Snijder E. J., Fang Y., Nonstructural protein 2 of porcine reproductive and respiratory syndrome virus inhibits the antiviral function of interferon-stimulated gene 15. Journal Virology 2012 86 7 3839 3850 10.1128/JVI.06466-11
116. Guerra S., Cáceres A., Knobeloch K. P., Horak I., Esteban M., Vaccinia virus E3 protein prevents the antiviral action of ISG15. Plos Pathogens 2008 4 7 2-s2.0-48249105524 10.1371/journal.ppat.1000096 e1000096